✦ LIBER ✦

Past hepatitis B virus infection in rheumatoid arthritis patients receiving biological and/or nonbiological disease-modifying antirheumatic drugs

✍ Scribed by Shunsuke Mori

Publisher: Springer
Year: 2011
Tongue: English
Weight: 170 KB
Volume: 21
Category: Article
ISSN: 1439-7595
DOI: 10.1007/s10165-011-0458-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of nonbiologic disease-modifying ant

Use of nonbiologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritis

✍ Lacaille, Diane ;Guh, Daphne P. ;Abrahamowicz, Michal ;Anis, Aslam H. ;Esdaile, 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 2 views

American College of Rheumatology 2008 re

American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis

✍ Saag, Kenneth G. ;Teng, Gim Gee ;Patkar, Nivedita M. ;Anuntiyo, Jeremy ;Finney, 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 315 KB 👁 2 views

Guidelines and recommendations developed and/or endorsed by the American College of Rheumatology (ACR) are intended to provide guidance for particular patterns of practice and not to dictate the care of a particular patient. The ACR considers adherence to these guidelines and recommendations to be v

Safety of the selective costimulation mo

Safety of the selective costimulation modulator abatacept in rheumatoid arthritis patients receiving background biologic and nonbiologic disease-modifying antirheumatic drugs: A one-year randomized, placebo-controlled study

✍ M. Weinblatt; B. Combe; A. Covucci; R. Aranda; J. C. Becker; E. Keystone 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB 👁 2 views

Inclusion of glucocorticoids in recommen

Inclusion of glucocorticoids in recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis: Comment on the article by Saag et al

✍ van Tuyl, L. H. D. ;Lems, W. F. ;Voskuyl, A. E. ;Dijkmans, B. A. C. ;Boers, M. ; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB 👁 3 views

The 2008 American College of Rheumatolog

The 2008 American College of Rheumatology recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis: Where the rubber meets the road

✍ Bathon, Joan M. ;Cohen, Stanley B. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 51 KB 👁 2 views

Similar effects of disease-modifying ant

✍ Niels Graudal; Gesche Jürgens 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB 👁 2 views

## Abstract ## Objective To define the differences in effects on joint destruction in rheumatoid arthritis (RA) patients between therapy with single and combination disease‐modifying antirheumatic drugs (DMARDs), glucocorticoids, and biologic agents. ## Methods Randomized controlled trials in RA